Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jae-Gook Shin

Showing results (171-180 of 256) with videos related to

Pageof 26
Sort By:
Frontiers in Cellular and Infection Microbiology|February 27, 2023
Advancing personalized medicine for tuberculosis through the application of immune profilingVo Thuy Anh Thu, Ly Da Dat, Rannissa Puspita Jayanti, et al.
Clinical Pharmacology and Therapeutics|December 21, 2006
Effect of CYP3A5*3 genotype on the pharmacokinetics and pharmacodynamics of amlodipine in healthy Korean subjectsKyoung-Ah Kim, Pil-Whan Park, Ock-Je Lee, et al.
Biomedical Chromatography : BMC|February 7, 2008
Determination of acetylsalicylic acid and its major metabolite, salicylic acid, in human plasma using liquid chromatography-tandem mass spectrometry: application to pharmacokinetic study of Astrix in Korean healthy volunteersSoo Kyung Bae, Kyung Ah Seo, Eun Ji Jung, et al.
Thrombosis Research|January 11, 2011
Identification of P2Y12 single-nucleotide polymorphisms and their influences on the variation in ADP-induced platelet aggregationSu-Jun Lee, Il-Sun Jung, Eun-Ji Jung, et al.
Toxicology Letters|April 24, 2004
Induction of inducible nitric oxide synthase and proinflammatory cytokines expression by o,p'-DDT in macrophagesJi Young Kim, Chul Yung Choi, Kyung Jin Lee, et al.
Pharmacogenetics|March 5, 2002
Effects of CYP2C19 and CYP2C9 genetic polymorphisms on the disposition of and blood glucose lowering response to tolbutamide in humansJi-Hong Shon, Young-Ran Yoon, Kyoung-Ah Kim, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 16, 2007
Identification and functional characterization of genetic variants of human organic cation transporters in a Korean populationHo-Jin Kang, Im-Sook Song, Ho Jung Shin, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|July 19, 2014
Glucuronidation of fimasartan, a new angiotensin receptor antagonist, is mainly mediated by UGT1A3Eun-Sook Jeong, Yang-Weon Kim, Hyo-Ji Kim, et al.
Journal of Pharmaceutical and Biomedical Analysis|September 15, 2014
Simple and accurate quantitative analysis of 20 anti-tuberculosis drugs in human plasma using liquid chromatography-electrospray ionization-tandem mass spectrometryHyo-Ji Kim, Kyung-Ah Seo, Hyun-Mi Kim, et al.
Cancer Chemotherapy and Pharmacology|November 24, 2014
Association of ABCG2 polymorphism with clinical efficacy of imatinib in patients with gastrointestinal stromal tumorDong-Hoe Koo, Min-Hee Ryu, Baek-Yeol Ryoo, et al.
Pageof 26

Showing results (171-180 of 256) with videos related to

Sort By:
Pageof 26
Frontiers in Cellular and Infection Microbiology|February 27, 2023
Advancing personalized medicine for tuberculosis through the application of immune profilingVo Thuy Anh Thu, Ly Da Dat, Rannissa Puspita Jayanti, et al.
Clinical Pharmacology and Therapeutics|December 21, 2006
Effect of CYP3A5*3 genotype on the pharmacokinetics and pharmacodynamics of amlodipine in healthy Korean subjectsKyoung-Ah Kim, Pil-Whan Park, Ock-Je Lee, et al.
Biomedical Chromatography : BMC|February 7, 2008
Determination of acetylsalicylic acid and its major metabolite, salicylic acid, in human plasma using liquid chromatography-tandem mass spectrometry: application to pharmacokinetic study of Astrix in Korean healthy volunteersSoo Kyung Bae, Kyung Ah Seo, Eun Ji Jung, et al.
Thrombosis Research|January 11, 2011
Identification of P2Y12 single-nucleotide polymorphisms and their influences on the variation in ADP-induced platelet aggregationSu-Jun Lee, Il-Sun Jung, Eun-Ji Jung, et al.
Toxicology Letters|April 24, 2004
Induction of inducible nitric oxide synthase and proinflammatory cytokines expression by o,p'-DDT in macrophagesJi Young Kim, Chul Yung Choi, Kyung Jin Lee, et al.
Pharmacogenetics|March 5, 2002
Effects of CYP2C19 and CYP2C9 genetic polymorphisms on the disposition of and blood glucose lowering response to tolbutamide in humansJi-Hong Shon, Young-Ran Yoon, Kyoung-Ah Kim, et al.
Drug Metabolism and Disposition: the Biological Fate of Chemicals|January 16, 2007
Identification and functional characterization of genetic variants of human organic cation transporters in a Korean populationHo-Jin Kang, Im-Sook Song, Ho Jung Shin, et al.
Xenobiotica; the Fate of Foreign Compounds in Biological Systems|July 19, 2014
Glucuronidation of fimasartan, a new angiotensin receptor antagonist, is mainly mediated by UGT1A3Eun-Sook Jeong, Yang-Weon Kim, Hyo-Ji Kim, et al.
Journal of Pharmaceutical and Biomedical Analysis|September 15, 2014
Simple and accurate quantitative analysis of 20 anti-tuberculosis drugs in human plasma using liquid chromatography-electrospray ionization-tandem mass spectrometryHyo-Ji Kim, Kyung-Ah Seo, Hyun-Mi Kim, et al.
Cancer Chemotherapy and Pharmacology|November 24, 2014
Association of ABCG2 polymorphism with clinical efficacy of imatinib in patients with gastrointestinal stromal tumorDong-Hoe Koo, Min-Hee Ryu, Baek-Yeol Ryoo, et al.
Pageof 26